MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

MDT

97.17

+1.83%↑

VEEV

296.22

-0.33%↓

A

141.1

+1.69%↑

HQY

89.15

-1.44%↓

PHR.US

23.34

+3.41%↑

Search

Cumberland Pharmaceuticals Inc

Открыт

3.17

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

3.1

Макс.

3.2

Ключевые показатели

By Trading Economics

Доход

-2M

-735K

Продажи

-876K

11M

Рентабельность продаж

-6.784

Сотрудники

91

EBITDA

-878K

414K

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+12.18% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

6 нояб. 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-13M

47M

Предыдущая цена открытия

3.17

Предыдущая цена закрытия

3.17

Техническая оценка

By Trading Central

Уверенность

Very Strong Bearish Evidence

Cumberland Pharmaceuticals Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

2 окт. 2025 г., 23:30 UTC

Популярные акции

Stocks to Watch: Rumble, Applied Materials, American Outdoor Brands

2 окт. 2025 г., 21:21 UTC

Отчет

Applied Materials Expects New Export Rule to Hit 2026 Revenue by $600 Million

3 окт. 2025 г., 00:00 UTC

Приобретения, слияния, поглощения

Warren Buffett's Berkshire Comes to the Aid of Occidental Petroleum -- Again -- WSJ

2 окт. 2025 г., 23:40 UTC

Обсуждения рынка

Gold Edges Higher, Aided by Risks U.S. Shutdown May Weaken Economy -- Market Talk

2 окт. 2025 г., 23:39 UTC

Обсуждения рынка

Japanese Stocks May Edge Higher, Tracking Wall Street Gains -- Market Talk

2 окт. 2025 г., 23:29 UTC

Приобретения, слияния, поглощения

Vistra: Transaction Remains on Track to Close This Qtr or 1Q 2026 >VST

2 окт. 2025 г., 23:29 UTC

Приобретения, слияния, поглощения

Vistra: Received Regulatory Approval From FERC for Acquisition of Certain Subsidiaries Owning Seven Natural-Gas Generation Facilities From Lotus Infrastructure Partners >VST

2 окт. 2025 г., 23:29 UTC

Приобретения, слияния, поглощения

Vistra: Next Step in Acquisition of Gas Generation Fleet With Approval From Federal Energy Regulatory Commission

2 окт. 2025 г., 23:00 UTC

Обсуждения рынка

Warehouse Needs Time to Restore Credibility With Investors -- Market Talk

2 окт. 2025 г., 22:54 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Scales's JV Buyout Lauded by Bull -- Market Talk

2 окт. 2025 г., 22:54 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Global Forex and Fixed Income Roundup: Market Talk

2 окт. 2025 г., 22:46 UTC

Обсуждения рынка

Synlait Milk Loses Bear Following Sale of North Island Assets -- Market Talk

2 окт. 2025 г., 22:46 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

2 окт. 2025 г., 21:17 UTC

Приобретения, слияния, поглощения

Buffett Scores Win in Berkshire's Deal for Occidental Chemicals Unit -- Barrons.com

2 окт. 2025 г., 20:50 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Energy & Utilities Roundup: Market Talk

2 окт. 2025 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

2 окт. 2025 г., 20:49 UTC

Приобретения, слияния, поглощения

OpenAI's Latest Funding Deal Returns Focus to AI Economy, Lifting U.S. Stocks -- WSJ

2 окт. 2025 г., 20:00 UTC

Приобретения, слияния, поглощения

Legrand Signs Definitive Agreement To Acquire Avtron Power Solutions, A Global Provider Of Load Banks & Power Quality Solutions >LR.FR

2 окт. 2025 г., 19:20 UTC

Обсуждения рынка

Natural Gas Snaps Winning Streak Despite Small Inventory Rise -- Market Talk

2 окт. 2025 г., 19:10 UTC

Обсуждения рынка

Bank of Canada to Publish Inflation Dashboard in 2026 -- Market Talk

2 окт. 2025 г., 19:04 UTC

Обсуждения рынка

Oil Futures Extend Losses as Markets Brace for Higher Output -- Market Talk

2 окт. 2025 г., 18:46 UTC

Приобретения, слияния, поглощения

Honeywell: Transaction Expected to Improve Annual Free Cash Flow by More Than $100 M Over Next Several Years and Then Decrease Over Time >HON

2 окт. 2025 г., 18:46 UTC

Приобретения, слияния, поглощения

Honeywell: Loss Will Be Excluded From Adjusted EPS >HON

2 окт. 2025 г., 18:46 UTC

Приобретения, слияния, поглощения

Honeywell: Estimated Impact of Divestiture Will Be One-Time Loss of About $115 M >HON

2 окт. 2025 г., 18:45 UTC

Приобретения, слияния, поглощения

Honeywell Will Have No Further Fincl Exposure to the Transferred Liabilities >HON

2 окт. 2025 г., 18:45 UTC

Приобретения, слияния, поглощения

Honeywell Utilized Portion of Cash From Resideo Indemnification and Reimbursement Agreement Termination to Fund Delticus Transaction >HON

2 окт. 2025 г., 18:44 UTC

Приобретения, слияния, поглощения

Honeywell: Delticus Assumed Full Responsibility for Administering and Resolving All Current and Future Asbestos-Related Claims >HON

2 окт. 2025 г., 18:44 UTC

Приобретения, слияния, поглощения

Honeywell and Delticus Contributed About $1.68 B in Cash, as Well as Certain Insurance Assets Related to Legacy Asbestos Liabilities >HON

2 окт. 2025 г., 18:44 UTC

Приобретения, слияния, поглощения

Honeywell: Transaction Strengthens Annual Free Cash Flow Generation >HON

2 окт. 2025 г., 18:43 UTC

Приобретения, слияния, поглощения

Honeywell Divested All Legacy Bendix Asbestos Liabilities, as Well as Certain Non-Bendix Asbestos Liabilities, to Delticus >HON

Сравнение c конкурентами

Изменение цены

Cumberland Pharmaceuticals Inc Прогноз

Целевая цена

By TipRanks

12.18% рост

Прогноз на 12 месяцев

Средняя 3.5 USD  12.18%

Максимум 3.5 USD

Минимум 3.5 USD

Основано на мнении 1 аналитиков Wall Street, спрогнозировавших целевые цены для Cumberland Pharmaceuticals Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

1 ratings

0

Покупка

1

Удержание

0

Продажа

Техническая оценка

By Trading Central

4.325 / 4.845Поддержка и Сопротивление

Краткосрочная

Very Strong Bearish Evidence

Среднесрочная

Strong Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.
help-icon Live chat